As compared to patients who had a high adherence to angiotensin-II stimulating drugs, those with a low adherence had an insignificantly elevated risk of AD and total ADRD, whereas those receiving angiotensin-II inhibiting drugs had a significantly higher risk of other dementia and total ADRD regardless of their high or low adherence. The gene discussed is AGT; the disease is dementia.